Ethics of Genetic Therapies

How do different stakeholders think about gene editing and the potential social and ethical implications?

For many years, scientists have been trying to develop medical treatments that could ‘correct’ genes that led to inherited conditions. In general these are called gene therapies, and more recently they use a new technique called gene editing. These treatments could be used on people of any age (called somatic gene therapy), and also could theoretically be used on eggs/sperm or embryos (called germline gene therapy) or on developing babies during a pregnancy (called prenatal gene editing).  

While gene editing is not happening in Switzerland (as of 2023), there are many clinical trial studies happening around the world and several hundred people have had somatic gene editing for a handful of different inherited conditions. While gene therapies and gene editing treatments could be a very exciting way to treat inherited conditions that previously did not have any treatment, or did not have an effective treatment, there are also some social and ethical implications to think about.  

Our lab is interested in how different stakeholders think about gene editing and the potential social and ethical implications. We are conducting a number of research studies in this area.

In German:

 

In French:

 

In English:

Reports on genome editing from international and non-governmental agencies:

JavaScript has been disabled in your browser